NYSE: DPLO

+0.29 +1.22% $ 24.10 Volume: 610,465 Common Stock | 20 minute delay February 16, 2018

One Patient at a Time.

Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: ‘‘Take good care of patients, and the rest falls into place.’’ Today, that tradition continues and we have focused on creating a culture that is highly focused on improving patient care and clinical adherence.

We believe that our primary focus on the patient differentiates us from our competition. We understand that the primary concerns of a patient facing a chronic and serious condition are quality of care and ease of working with the pharmacy. We believe that our detailed, well managed, high-touch patient care program that is designed to address these concerns is essential to our success. Our specialty drug dispensing and services business model creates partnerships with patients, payors, pharmaceutical manufacturers and physicians—with a focus on improving adherence and the patient experience.

Date Filing Filing Description Download
February 13, 2018 SC 13G Statement of Ownership
February 13, 2018 SC 13G/A Amended Statement of Ownership
February 12, 2018 SC 13G/A Amended Statement of Ownership

NYSE: DPLO

+0.29 +1.22% $ 24.10 Volume: 610,465 Common Stock | 20 minute delay February 16, 2018

Investor Contact

Asher S. Dewhurst

Investor Relations,
Westwicke Partners, LLC.
diplomat@westwicke.com

Phone: 443.213.0500

Email Now